Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /541096
chevron_leftBack

Bharat Parenterals Ltd.

541096
BSE: 541096 Delayed
973.90INR -1.2%
11.39 USD
As of 24 April 2025, Bharat Parenterals Ltd. has a market cap of $76.42M USD, ranking #22226 globally and #1613 in India. It ranks #2220 in the Healthcare sector, and #495 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
22226
Country Rank
1613
Sector Rank
2220
Industry Rank
495
Key Stats
Market Cap
$76.42MUSD
6.52B INR
Enterprise Value
$89.25MUSD
7.63B INR
Revenue (TTM)
$35.89MUSD
3.06B INR
EBITDA (TTM)
-$1.59MUSD
-136.32M INR
Net Income (TTM)
-$962.48KUSD
-82.13M INR
EBITDA Margin
-4.5%
Profit Margin
-2.7%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Bharatkumar Desai open_in_new
Employees
363
Founded
1992
Website
bplindia.in open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.2% -0.9% -6.2% -34% -30% -33%
Upcoming Earnings
Earnings Date
Tue, May 20

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
541096 (BPLPHARMA)
Bharat Parenterals Ltd
ISIN: INE365Y01019
Shares Out.:
6.892M1 Shares Float: 2.635M2
TV:
SA:
YF:
GF:
BA:
MS:
973.90 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bharat Parenterals Ltd.

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India. The company provides products in the areas of antibiotics, anti-retroviral, antiprotozoal/anthelmintic, respiratory, antiallergic/anti-histaminic/anticold, cleansing agents/skin infections, cardiovascular systems, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastrointestinal tract/alimentary systems, anti-inflammatory/anti-pyretic/analgesics, supplements, central nervous system, anaesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer, and others. It also provides general products, β-lactum /cephalosporin products, and formulations. The company offers its products in the form of tablets, capsules, liquid-orals, ointments, creams, lotions, suspensions, syrups, powders, oral solutions and drops, gels, vaginal inserts, nebulizers, elixiers, eye drops, infusions, nasal drops, and powdered injections, as well as in ampoules and vials. It serves biopharmaceuticals startup and pharmaceutical companies. The company also exports its products internationally. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
64K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
24K%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
19K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
17K%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
16K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
88K%
Merck KGaA
MRK
$59.42B
52.43B EUR
78K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
61K%
Haleon plc
HLN
$45.57B
34.34B GBP
60K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
30K%